Chun-Yi Wu

Dr. Chun-Yi Wu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
CWChun-Yi Wu
Chun-Yi Wu
JLJia-Jia Lin
Jia-Jia Lin
WCWen-Yi Chang
Wen-Yi Chang
CHCheng-Ying Hsieh
Cheng-Ying Hsieh
CWChin-Ching Wu
Chin-Ching Wu
WKWei-Ying Kuo
Wei-Ying Kuo

17 December 2020 in Oncogene
Verified
Journal Article
Open access
PDF file
FCFang-Ju Cheng
Fang-Ju Cheng
CCChia-Hung Chen
Chia-Hung Chen
WTWen-Chen Tsai
Wen-Chen Tsai
BWBo-Wei Wang
Bo-Wei Wang
MYMeng-Chieh Yu
Meng-Chieh Yu
Wei-Chien HuangWei-Chien Huang
Wei-Chien Huang
Smoker patients with non-small cell lung cancer (NSCLC) have poorer prognosis and survival than those without smoking history. However, the mechanisms underlying the low response rate of those patients to EGFR tyrosine kinase inhibitors (TKIs) are not well understood. Here we report that exposure to cigarette smoke extract enhances glycolysis and attenuates AMP-activated protein kinase (AMPK)-dependent inhibition of mTOR; this in turn reduces the sensitivity of NSCLC cells with wild-type EGFR (EGFRWT) to EGFR TKI by repressing expression of liver kinase B1 (LKB1), a master kinase of the AMPK subfamily, via CpG island methylation. In addition, LKB1 expression is correlated positively with sensitivity to TKI in patients with NSCLC. Moreover, combined treatment of EGFR TKI with AMPK activators synergistically increases EGFR TKI sensitivity. Collectively, the current study suggests that LKB1 may serve as a marker to predict EGFR TKI sensitivity in smokers with NSCLC carrying EGFRWTand that the combination of EGFR TKI and AMPK activator may be a potentially effective therapeutic strategy against NSCLC with EGFRWT.

Verified
Journal Article
Open access
PDF file
CWChun-Yi Wu
Chun-Yi Wu
HHHsin-Hua Hsieh
Hsin-Hua Hsieh
TCTing-Yu Chang
Ting-Yu Chang
JLJia-Jia Lin
Jia-Jia Lin
CWChin-Ching Wu
Chin-Ching Wu
SPShin-Lei Peng
Shin-Lei Peng
This study aimed to develop a novel magnetic resonance imaging (MRI)-detectable boron (B)-containing nanoassemblies and evaluate their potential for boron neutron capture therapy (BNCT). Starting from the citrate-coated gold nanoparticles (AuNPs) (23.9 ± 10.2 nm), the diameter of poly (D, L-lactide-co-glycolide) AuNPs (PLGA-AuNPs) increased approximately 110 nm after the encapsulation of the PLGA polymer. Among various B drugs, the self-produced B cages had the highest loading efficiency. The average diameter of gadolinium (Gd)- and B-loaded NPs (PLGA-Gd/B-AuNPs) was 160.6 ± 50.6 nm with a B encapsulation efficiency of 28.7 ± 2.3%. In vitro MR images showed that the signal intensity of PLGA-Gd/B-AuNPs in T1-weighted images was proportional to its Gd concentration, and there exists a significantly positive relationship between Gd and B concentrations (R2 = 0.74, p < 0.005). The hyperintensity of either 250 ± 50 mm3 (larger) or 100 ± 50 mm3 (smaller) N87 xenograft was clearly visualized at 1 h after intravenous injection of PLGA-Gd/B-AuNPs. However, PLGA-Gd/B-AuNPs stayed at the periphery of the larger xenograft while located near the center of the smaller one. The tumor-to-muscle ratios of B content, determined by inductively coupled plasma mass spectrometry, in smaller- and larger-sized tumors were 4.17 ± 1.42 and 1.99 ± 0.55, respectively. In summary, we successfully developed theranostic B- and Gd-containing AuNPs for BNCT in this study.

10 April 2014 in Journal of Applied Physics
Verified
Journal Article
Closed access
PDF file
WLWen-Chung Lu
Wen-Chung Lu
HNHoang-Diem Nguyen
Hoang-Diem Nguyen
CWChun-Yi Wu
Chun-Yi Wu
KCKao-Shuo Chang
Kao-Shuo Chang
Masahiro YOSHIMURAMasahiro YOSHIMURA
Masahiro YOSHIMURA
Facile polymerized complex reactions together with a hydrothermal reaction were implemented to make single crystalline TiO2 nanorods for the first time. Chromium (Cr) and nitrogen (N2) co-doping was performed to tailor the physical properties. Transmission electron microscopy and x-ray diffraction study illustrated that highly reactive facets of (101), (111), and (001) dominated rutile TiO2 nanorods. A growth model, based on formation of complex species, was proposed to elucidate effectiveness of the soft solution processing in making TiO2 nanorods. X-ray photoelectron spectroscopy analysis and consideration of fundamentals of charge neutrality showed N2 doping could inhibit formation of Cr6+ and oxygen vacancies (VO2+). An investigation of the photocatalytic properties exhibited high efficiency of photodegradation of methylene blue in 15 min under pH = 10, using a nanocomposite of (7% Cr, 0.0021% N) codoped and 3% Cr doped TiO2 nanorods.

12 March 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
WKWei-Ying Kuo
Wei-Ying Kuo
CWChun-Yi Wu
Chun-Yi Wu
LHLuen Hwu
Luen Hwu
JLJhih-Shian Lee
Jhih-Shian Lee
CTCheng-Han Tsai
Cheng-Han Tsai
RLRen-Shyan Liu
Ren-Shyan Liu
Cancer stem cells (CSCs) are usually tolerant to chemotherapy and radiotherapy and associated with tumor relapse. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor (HDACI), is currently being used in clinical trials of lung cancer. However, SAHA facilitates the formation of induced pluripotent stem cells from somatic cells. We hypothesized that SAHA would mediate the CSCs properties and subsequently confer a more malignant phenotype in lung cancer. Transfected H1299 lung cancer cells, which stably expresses a triple fused reporter gene (DsRedm-Fluc-tTKsr39) under the control of CMV promoter was used to establish a xenograft mouse model. After the treatment of SAHA, H1299 cell line and tumor xenografts were sorted by fluorescence-activated cell sorting (FACS) based on aldehyde dehydrogenase (ALDH) activity. We found that SAHA could suppress the growth of xenografted H1299 tumors with decreased proportion of ALDHbr lung cancer cells indicating that SAHA may target CSCs. However, SAHA significantly enhanced the tumor initiating capacity and the expression of malignant genes such as KCNMA1, MORF4L2 and ASPM in the remaining living ALDHbr cells. These findings suggested that SAHA treatment created a more drug-resistant state in residual ALDHbr cells. The in vivo imaging technique may facilitate searching and characterization of CSCs.

22 December 2023 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
HHHsin-Hua Hsieh
Hsin-Hua Hsieh
CCChuan-Lin Chen
Chuan-Lin Chen
HCHui-Wen Chan
Hui-Wen Chan
KCKwan-Hwa Chi
Kwan-Hwa Chi
CWChun-Yi Wu
Chun-Yi Wu